Strategic Transformation 2023 slide image

Strategic Transformation 2023

All Treated RUBY Patients are VOE-free Since Reni-cel Infusion editas MEDICINE Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient 9 Patient 10 6 11 11 7 7 7 9 4 12 VOES Prior to Informed Consent -25 -20 -15 -10 -5 Months Prior to Informed Consent 0* 0^ VOE-free After Reni-cel Infusion 5 Months of Post-Reni-cel Follow-up 10 Data cutoff November 22, 2023. Due to limited follow up period after dosing, Patient 11 was not included. Left panel ends at informed consent date: *Day of informed consent. Right panel starts at infusion date: ^Day reni-cel was infused. reni-cel, renizgamglogene autogedtem cel; VOE, vaso-occlusive event. Hanna R et al. Poster presented at ASH 2023; San Diego, CA, USA, 9-12 December. 15 All 10 patients who reached the Month 1 visit have been VOE-free since reni-cel infusion Ruby Severe VOE Non-severe VOE 9
View entire presentation